Researchers identified criteria and non-criteria features associated with SLE, which can be used in classification criteria.
Results from the phase 3 SELECT-CHOICE study comparing treatment with upadacitinib to abatacept, a selective T cell costimulation modulator, in adults with moderate to severe active rheumatoid arthritis.
An investigational type 1 interferon receptor inhibitor was associated with significant reduction in disease activity in patients with systemic lupus erythematosus.
Researchers evaluated the effect of anti-acid treatment on disease progression in systemic sclerosis interstitial lung disease.
Researchers evaluated the efficacy and safety of avacopan for the treatment of ANCA-associated vasculitis.
Researchers quantified the comparative effect of csDMARDs on the risk for myocardial infarction and stroke in rheumatoid arthritis.
The association between juvenile idiopathic arthritis and autism spectrum condition was explored.
Patients with ankylosing spondylitis were found to be at an elevated risk of developing aortic valve regurgitation.
In a study of lenabasum treatment in systemic sclerosis, researchers evaluated variability of immunosuppressive therapy by geographic region; includes Q&A with study lead author, Dr Christopher Denton.
The efficacy of active conventional therapy in early rheumatoid arthritis was examined.